Suchergebnisse - (Person:"Wu, Jiajing")

PubPharm (156)

101

SARS-CoV-2 501Y.V2 variants lack higher infectivity but do have immune escape

enthalten in: Cell | 2021

von Li, Q. | Nie, J. | Wu, J. | +24

CommentIn: Signal Transduct Target Ther. 2021 Jul 27;6(1):284. - PMID 34315847

102

Functional comparison of SARS-CoV-2 with closely related pangolin and bat coronaviruses

enthalten in: Cell discovery | 2021

von Nie, J. | Li, Q. | Zhang, L. | +21

103

The Infectivity and Antigenicity of Epidemic SARS-CoV-2 Variants in the United Kingdom

enthalten in: ResearchSquare.com | 2021

von Wang, Y. | Wu, J. | Zhang, L. | +11

104

TRPS1 drives heterochromatic origin refiring and cancer genome evolution

enthalten in: Cell reports | 2021

von Yang, J. | Liu, X. | Huang, Y. | +12

105

Clofazimine salt compound, preparation method and application thereof

enthalten in: Europäisches Patentamt | 2021

von WANG YOUCHUN | SONG DANQING | LIU QIANG | +8

106

High-Throughput Screening and Identification of Human Adenovirus Type 5 Inhibitors

enthalten in: Frontiers in cellular and infection microbiology | 2021

von Wen, X. | Zhang, L. | Zhao, S. | +6

107

Spike-specific circulating T follicular helper cell and cross-neutralizing antibody responses in COVID-19-convalescent individuals

enthalten in: Nature microbiology | 2021

von Zhang, J. | Wu, Q. | Liu, Z. | +31

108

Clofazimine : A Promising Inhibitor of Rabies Virus

enthalten in: Frontiers in pharmacology | 2021

von Wu, J. | Cao, S. | Lei, S. | +13

109

The Antigenicity of Epidemic SARS-CoV-2 Variants in the United Kingdom

enthalten in: Frontiers in immunology | 2021

von Wu, J. | Zhang, L. | Zhang, Y. | +11

110

Construct a Knowledge Graph for China Coronavirus (COVID-19) Patient Information Tracking

enthalten in: Risk management and healthcare policy | 2021

von Wu, J.